Vietnam has decided to incorporate Health Technology Assessment (HTA) evidence to support reimbursement decisions for medicines and has recognised the need for standard guidelines for both the process and the methodological aspects of HTA. The Health Strategy and Policy Institute (HSPI),
Ministry of Health (MOH), Vietnam, which is the main organization responsible for the development of the HTA methodological guideline, is the focal point on health technology assessment as assigned
by the Ministry of Health of Vietnam, whereas the Department of Health Insurance under the Ministry of Health is in charge of the development of the process guideline.
During 2014-2018, HSPI, with support from the Health Intervention and Technology Assessment Program (HITAP) under the auspices of the International Decision Support Initiative (iDSI), developed a HTA process manual for internal purposes, which was then used as the starting point for the Department of Health Insurance’s process guideline. HSPI conducted a stakeholder consultation on 24th January 2018 at the Ministry of Public Health to share the progress on its development and
provide stakeholders an opportunity to give feedback. The meeting was chaired by Prof. Pham Le Tuan and was participated by representatives from the Department of Health Insurance, the Director of the National Assembly Commission for Social Affairs, and directors of hospitals in Vietnam.
HSPI has gathered academic experts who are experienced in conducting HTA to form a technical team
to develop the methodological guideline. The technical team has been developing the draft guideline
since September 2017 and the work is currently ongoing. On 25th January 2018, HSPI convened the
technical team to discuss the progress of the guidelines’ development. The agenda of the visit is
provided in Annex 1.
For the full report please click here